June 12th, 2023
Reel hope for ocean conservation
Creating sustainable, cell-cultured fish fillets using cardiac tissue engineering techniques.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Licensing
September 1st, 2022
Fast charging over 10,000 cycles: For future electric vehicles, Harvard engineers’ solid-state battery technology points to a leap in performance and reliability
Startup Adden Energy granted technology license from Harvard to scale innovative lithium-metal battery technology for commercial deployment
June 27th, 2022
Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases
The startup will develop and commercialize cost-effective, highly sensitive and specific point-of-care diagnostics, applying a novel electrochemical sensor platform created at the Wyss Institute
March 7th, 2022
Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics
Low-cost, multiplexed, electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics
February 23rd, 2022
Cantex licenses IP from Harvard to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
Organ Chip studies revealed azeliragon can reduce virus-associated inflammation in human lung tissue
